Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Associated Press - November 26, 2004
The first-stage test of the vaccine to determine its safety is to be carried out on 30 volunteers aged 18-50, state television said on its midday news. It said details of the test would be announced later.
The experimental vaccine was developed by Chinese scientists who have studied the genetics of the AIDS virus since 1996, the Xinhua News Agency said, citing the State Food and Drug Administration.
"Researchers attacked a monkey with (the) AIDS virus after injecting the compound vaccine into its body, and found no abnormal reactions occurred," the report said.
The announcement came as China prepared to mark World AIDS Day on Wednesday.
China says it has 840,000 people infected with the AIDS virus and 80,000 with the full-blown disease. But health experts say the true figures are much higher and warn that China could have 10 million people infected by 2010 unless it takes urgent action.
The communist government has become more open about its AIDS epidemic after years of denying the disease was a problem, though AIDS activists are still regularly detained and harassed.
State television quoted a spokesman for the drug agency as cautioning that the experimental vaccine would require lengthy testing.
"Experiments with this drug don't necessarily mean the drug will be a success," the spokesman said. "We do not expect that such vaccinations will be available to the public within a short time."
In the world's biggest study of an experimental AIDS vaccine, Thai and U.S. researchers have been testing a combination of two drugs on 16,000 Thai volunteers since 2003.
The State Food and Drug Administration also promised to "accelerate approval process of all kinds of anti-AIDS drugs to help speed up relevant clinical researches," Xinhua said.
Plans to distribute condoms at elite Peking University for World AIDS Day were canceled after school officials objected to carrying out the distribution in public.
041126
AP041158
Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .